Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2014 | Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence | CHUN-JEN LIU ; Chang J.; PO-HUANG LEE ; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; MING-CHIH HO ; Yang S.-S.; Yang M.-D.; Yu M.-C.; REY-HENG HU ; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN | World Journal of Gastroenterology | 53 | 51 | |
2013 | Adverse outcomes after noncardiac surgery in patientswith diabetes: A nationwide population-based retrospective cohort study | Yeh C.-C.; Liao C.-C.; YI-CHENG CHANG ; Jeng L.-B.; Yang H.-R.; Shih C.-C.; Chen T.-L. | Diabetes Care | 58 | 55 | |
2010 | Anatomical Asymmetry in Goiter: A Demonstration by Three-dimensional Power Doppler Ultrasound | Hsieh M.-H.; Chiou S.-C.; Chen C.-C.; Hsu W.-H.; Jeng L.-B.; YI-CHENG CHANG ; Lin J.-D. | Journal of Medical Ultrasound | 0 | 0 | |
2013 | Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: Results from the randomized phase III BRISK-FL study | Johnson P.J.; Qin S.; Park J.-W.; Poon R.T.P.; Raoul J.-L.; Philip P.A.; CHIH-HUNG HSU ; Hu T.-H.; Heo J.; Xu J.; Lu L.; Chao Y.; Boucher E.; Han K.-H.; Paik S.-W.; Robles-Aviña J.; Kudo M.; Yan L.; Sobhonslidsuk A.; Komov D.; Decaens T.; Tak W.-Y.; Jeng L.-B.; Liu D.; Ezzeddine R.; Walters I.; ANN-LII CHENG | Journal of Clinical Oncology | 618 | 595 | |
2009 | Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage | CHUN-JEN LIU ; PO-HUANG LEE ; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; MING-CHIH HO ; Yang S.-S.; Lee C.-C.; Yu M.-C.; REY-HENG HU ; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN | Journal of Hepatology | 131 | 125 | |
2013 | Hepatic resection for hepatocellular carcinoma patients on hemodialysis for Uremia: A nationwide cohort study | Yeh C.-C.; Lin J.-T.; Jeng L.-B.; Charalampos I.; Chen T.-T.; Lee T.-Y.; MING-SHIANG WU ; Kuo K.N.; Liu Y.-Y.; Wu C.-Y. | World Journal of Surgery | 16 | 17 | |
2012 | Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection | Chen L.-T.; Chen M.-F.; Li L.-A.; PO-HUANG LEE ; Jeng L.-B.; Lin D.-Y.; Wu C.-C.; Mok K.-T.; Chen C.-L.; Lee W.-C.; Chau G.-Y.; Chen Y.-S.; Lui W.-Y.; Hsiao C.-F.; Whang-Peng J.; PEI-JER CHEN | Annals of Surgery | 111 | 106 | |
2015 | Long-term risk of acute coronary syndrome in splenectomized patients due to splenic injury | Tsai M.-S.; Chou S.-E.; HONG-SHIEE LAI ; Jeng L.-B.; Lin C.-L.; Kao C.-H. | Medicine (United States) | 6 | 8 | |
2015 | Nonsteroidal anti-inflammatory drugs are associated with reduced risk of early hepatocellular carcinoma recurrence after curative liver resection: A nationwide cohort study | Yeh C.-C.; Lin J.-T.; Jeng L.-B.; Ho H.J.; Yang H.-R.; MING-SHIANG WU ; Kuo K.N.; Wu C.-Y. | Annals of Surgery | 43 | 41 | |
2008 | Osteoblast-derived TGF-β1 stimulates IL-8 release through AP-1 and NF-κB in human cancer cells | Fong Y.-C.; Maa M.-C.; Tsai F.-J.; Chen W.-C.; Lin J.-G.; Jeng L.-B.; RONG-SEN YANG ; WEN-MEI FU ; Tang C.-H. | Journal of Bone and Mineral Research | 34 | 30 | |
2015 | Pre-existing diabetes and risks of morbidity and mortality after liver transplantation: A nationwide database study in an Asian population | Tsai M.-S.; Wang Y.-C.; Wang H.-H.; PO-HUANG LEE ; Jeng L.-B.; Kao C.-H. | European Journal of Internal Medicine | 17 | 15 |